Dengue Virus NS1 Antigen (Bio-Rad) Clinical Protocol
Study of Bio-Rad Laboratories Platelia Dengue NS1 Ag Assay in Blood Donors.
Sponsor: American National Red Cross
A observational or N/A phase clinical study on Mass Screening, this trial is completed. The trial is conducted by American National Red Cross and has accumulated 11 data snapshots since 2010. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Dec 2021 — Jul 2024 [monthly]
Completed
-
Jan 2021 — Dec 2021 [monthly]
Completed
-
Nov 2020 — Jan 2021 [monthly]
Completed
▶ Show 6 earlier versions
-
Jun 2018 — Nov 2020 [monthly]
Completed
-
May 2018 — Jun 2018 [monthly]
Completed
-
Apr 2018 — May 2018 [monthly]
Completed
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Completed NA
-
Feb 2017 — Aug 2017 [monthly]
Completed NA
-
Jan 2017 — Feb 2017 [monthly]
Completed NA
First recorded
Mar 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- American National Red Cross
- Bio-Rad Laboratories
- Centers for Disease Control and Prevention
For direct contact, visit the study record on ClinicalTrials.gov .